Keel Point, LLC Reata Pharmaceuticals Inc Transaction History

Keel Point, LLC

$1.19 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 03, 2023	SELL	$30.85 - $93.17 $1.34 Million - $4.04 Million	-43,333 Reduced 75.0%	14,446 $1.31 Million
Q2 2022 Aug 11, 2022	BUY	$20.71 - $36.5 $211,386 - $372,555	10,207 Added 21.46%	57,779 $1.25 Million
Q1 2022 Apr 27, 2022	BUY	$24.12 - $39.6 $361 - $594	15 Added 0.03%	47,572 $1.56 Million
Q4 2021 Jan 31, 2022	SELL	$25.61 - $110.96 $1.27 Million - $5.49 Million	-49,517 Reduced 51.01%	47,557 $1.25 Million
Q3 2021 Nov 04, 2021	BUY	$100.0 - $143.02 $9.71 Million - $13.9 Million	97,074 New	97,074 $9.77 Million
Q2 2021 Aug 06, 2021	SELL	$78.27 - $151.29 $7.65 Million - $14.8 Million	-97,723 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$78.27 - $151.29 $762,036 - $1.47 Million	-9,736 Reduced 9.06%	97,723 $13.8 Million
Q1 2021 May 17, 2021	SELL	$94.25 - $132.81 $536,282 - $755,688	-5,690 Reduced 5.03%	107,459 $10.7 Million
Q4 2020 Feb 10, 2021	SELL	$102.03 - $184.62 $725,637 - $1.31 Million	-7,112 Reduced 5.91%	113,149 $14 Million
Q3 2020 Nov 18, 2020	BUY	$93.53 - $163.34 $291,252 - $508,640	3,114 Added 2.66%	120,261 $11.7 Million
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $314,487 - $439,634	2,490 Added 2.17%	117,147 $18.3 Million
Q1 2020 May 01, 2020	BUY	$124.16 - $247.74 $166,871 - $332,962	1,344 Added 1.19%	114,657 $16.6 Million
Q4 2019 Feb 07, 2020	BUY	$74.57 - $217.92 $1.68 Million - $4.91 Million	22,552 Added 24.85%	113,313 $23.2 Million
Q3 2019 Nov 12, 2019	BUY	$71.26 - $95.75 $699,060 - $939,307	9,810 Added 12.12%	90,761 $7.29 Million
Q1 2019 May 14, 2019	SELL	$51.9 - $101.79 $98,610 - $193,401	-1,900 Reduced 2.29%	80,951 $6.92 Million
Q4 2018 Feb 08, 2019	BUY	$48.76 - $76.44 $184,312 - $288,943	3,780 Added 4.78%	82,851 $4.65 Million
Q2 2017 Aug 15, 2017	BUY	N/A	79,071	79,071 $2.5 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.

Account